| Abstract|| |
Background and Aims: Microscopic detection of decoy cells is routinely performed in urine samples from renal transplant patients for the evaluation of polyomaviruses. However, they are scanty papers evaluated the diagnostic accuracy of decoy cells in urine samples. The aim of this study is to evaluate the diagnostic accuracy of decoy cells in urine samples and compare with plasma real-time polymerase chain reaction (RT-PCR) as a gold standard method. In addition, to compare the findings of this study with other similar studies. Methods: A retrospective study over a period of four years from January 2014 to December 2017 was performed. A total of 89 urine samples from renal transplant patients were assessed for the presence of polyomaviruses and compared with plasma RT-PCR. The sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV) were measured. Results: There were 29 males and 18 females. The mean patient age was 40.3 years. The sensitivity, specificity, accuracy, PPV and NPV were 86.6%, 67.5%, 70.7%, 35.1% and 96.1%, respectively. Other similar studies reported a sensitivity of 41.9-84.6%, specificity of 65.8-100% and accuracy of 69.9-82%. Conclusion: The findings of this study show that the detection of decoy cells in urine samples is a sensitive screening method for polyomaviruses. The findings of this study are compatible with other similar studies.
Keywords: Decoy cells, polyomaviruses, renal transplants, real-time polymerase chain reaction, urine samples
|How to cite this article:|
Alwahaibi NY, Al Maskari TM, Aldairi N. Decoy cells versus plasma real-time polymerase chain reaction for the detection of polyomaviruses in renal transplant patients: A single institutional experience. J Cytol 2020;37:30-3
|How to cite this URL:|
Alwahaibi NY, Al Maskari TM, Aldairi N. Decoy cells versus plasma real-time polymerase chain reaction for the detection of polyomaviruses in renal transplant patients: A single institutional experience. J Cytol [serial online] 2020 [cited 2020 Jan 29];37:30-3. Available from: http://www.jcytol.org/text.asp?2020/37/1/30/273795
| Introduction|| |
BK and JC polyomaviruses are the major pathogenic viruses in humans. They are naturally found in healthy individuals without causing harms as about 70 – 90% of adults have antibodies against them. Following infection, these viruses remain latent, mainly in the renourinary tract, such as in the bladder transitional cell layer, renal pelvis, ureters and in tubular epithelial cells of the kidney. The activation of these viruses is increased during strong immunosuppression therapy usually after renal transplantation. This activation may lead to polyomavirus associated nephropathy (PVAN). PVAN is one of the major causes for allograft failure. PVAN is mainly caused by BK polyomaviruses, and to a lesser extent, by JC polyomaviruses. The incidence of PVAN ranges from 1% to 10% in renal transplant recipients.
Reactivation of polyomaviruses leads to the shedding of infected cells into urine, these cells called Decoy cells. These cells are easily identified in urine smears using routine Papanicolaou (PAP) or hematoxylin and eosin stains (H and E). Despite the use of urine cytology as a routine work, they are scanty papers evaluated the diagnostic accuracy of decoy cells in urine. The aim of this retrospective study was to compare the sensitivity, specificity, accuracy, positive predictive value and negative predictive value for routine decoy cells in urine samples with the plasma real-time polymerase chain reaction (RT-PCR) as a gold standard method. In addition, the findings of this study were compared with other similar studies.
| Methods|| |
A retrospective study over a period of four years from January 2014 to December 2017 was performed in the Department of Pathology, Sultan Qaboos University Hospital, Sultanate of Oman. The population was all renal transplant cases diagnosed for polyomavirus by both methods: urine cytology and plasma RT-PCR. This study was ethically approved by the Medical Research Committee and Ethics Committee at the College of Medicine and Health Sciences, Sultan Qaboos University, Sultanate of Oman. (MREC # 1538).
Urine samples were macroscopically evaluated for the volume, color and appearance. The samples were then centrifuged at 1800 rpm/5 min (centrifuge 5702, Eppendrof, Hamburg, Germany) and the supernatant was removed. Two microscopic slides were prepared for each urine sample and stained with PAP and H and E. Finally, the slides were screened by cytotechnologist and double checked by cytopathologist. Actually, the reporting terminology in cytology laboratory for positive cases of polyomaviruses were: adequate, negative for malignant cells and presence of decoy cells.
Plasma samples in EDTA preservative tubes were prepared for referral transportation. The primary reason for referral was because of the few number of cases. In abroad laboratory, polyomavirus nucleic acids were extracted using a Wizard TM Genomic DNA Purification kit (Promega Corporation. Madison, WI, USA). RT-PCR was applied using artus BK Virus RG PCR (QIAGEN GmbH, Hilden, Germany) which consists of a ready-to-use system for detection of BK virus DNA on Capillary based instrument (Rotor-Gene Q MDx/Rotor-Gene Q software version 1.7.94). The instrument consists of four program steps: denaturation, when DNA was melted and polymerase enzyme was activated. Annealing, when the reaction temperature was lowered allowing annealing of the primers to each of the single stranded DNA templates. Extension/elongation, the DNA polymerase synthesized new DNA strands. Cooling of the instrument at the end of each run. Finally, the results were analyzed using the instrument's software by measuring viral load for each sample.
The data were analyzed using the Statistical Package for the Social Sciences (SPSS) software version 23 (SPSS Inc., Chicago, IL, USA). Sensitivity, specificity, accuracy, positive predictive value (PPV), negative predictive value (NPV), false positive and false negative values were used for analysis of urine cytology compared to the plasma RT-PCR as a gold standard method.
| Results|| |
A total of 47 renal transplant patients were identified. There were 29 males and 18 females. The mean patient age was 40.3 years (age range being 16-68 years). A total of 89 urine cytology analysis were compatible with plasma quantitative RT-PCR tests which were performed in samples within three weeks. In contrast, the rest of the cases that had these two tests but the samples were collected in different dates were excluded from the study. Among 89 cases, the sensitivity, specificity, accuracy, PPV and NPV were 86.6%, 67.5%, 70.7%, 35.1% and 96.1%, respectively. Other parameters are shown in [Table 1]. An example of decoy cells in urine samples is shown in [Figure 1]. The findings of this study are comparable with other similar studies [Table 2].
|Table 1: Comparison between urine cytology and RT-PCR in the diagnosis of polyomaviruses in renal transplantpatients|
Click here to view
|Figure 1: Decoy cells in urine samples. (a) Papanicolaou method, ×600. (b) haematoxylin and eosin method, ×600|
Click here to view
|Table 2: Comparison between urine cytology and RT-PCR in the diagnosis of polyomaviruses in the current studyand other similar studies|
Click here to view
| Discussion|| |
The evaluation of urine cytology, via the detection of decoy cells in urine samples, in the diagnosis of PVAN is important for a better clinical management. It is widely used for the diagnosis of polyomaviruses. We do emphasis, as with others, that early screening for polyomaviruses in renal transplant patients may reduce the severity of PVAN.,, Until know, there is no effective treatment for polyomaviruses. The only available treatment method is to reduce the doses of immunosuppressive drugs with a close follow up. Thus, will improve and prolong graft survival.,
In this study, urine cytology shows an 86.6% sensitivity in the detection of polyomaviruses. This finding is higher than other similar studies.,, However, it is less than other study, which reported a sensitivity of 96.7%, when they compared urine cytology with the histopathological diagnosis of renal biopsy.
Urine cytology involves noninvasive method, cheaper than other methods such as renal biopsy, urine or plasma RT-PCR and electron microscope, easier to perform, and can be performed in a basic laboratory. Cytologically, decoy cells are usually identified by condensation of chromatin and large granular intranuclear inclusion bodies with a ground glass nucleus appearance. In addition, four different variants of decoy cells have been identified. Unfortunately, urine cytology cannot differentiate BK from JC polyomaviruses. Decoy cells could be the result of infection with BK, JC, or to a lesser extent, adenoviruses. However, it is very rare that JC polyomavirus causes PVAN., Although identification of decoy cells in urine smears is relatively easy, accurate diagnosis by cytoscreeners and cytopathologists is important to distinguish decoy cells from other viral infection, reactive atypia, urothelial dysplasia and malignant tumour cells. The major benefit of using RT-PCR in the diagnosis of polyomaviruses is that it can detect very low levels of the virus replication. However, RT- PCR analysis is expensive, difficult and contamination might be a problem. In fact, RT-PCR is only carried out in patients with persistent viruvia, as the RT-PCR result does not contribute in management decisions. Positive plasma RT PCR might indicate an increased risk for PVAN, but renal biopsy is essential for diagnosis. Histopathological diagnosis of renal biopsy samples is the definitive diagnosis of PVAN and more accurate than RT-PCR.
In the literature review, few studies compared plasma and urine PCR in detecting polyomaviruses in renal transplant patients. For example, Chung and colleagues demonstrated that both plasma and urine PCR showed 100% sensitivity and 100% NPV. However, specificity (91.8%) and PPV (27.3%) for urine PCR were less compared with plasma PCR, which showed specificity of 97.4% and PPV of 54.5%. Other two similar studies in Italy and USA revealed almost the same findings., It is important to note that the presence of polyomaviruses in renal transplant patients is first detected in urine then in plasma few weeks later and eventually in the renal tissue. This sequential order (viruria-viremia-nephritis) of virus replication in renal transplant patients fits with the diagnostic tests of urine cytology or urine PCR, plasma PCR and renal biopsy. Urine PCR is more specific than the detection of decoy cells in urine samples of renal transplant patients. Several researchers reported that the duration from viruria to viremia is one to three months, and from viremia to PVAN is one to twelve weeks.,, Thus, for an early detection of viruria, urine samples are more appropriate. Although there is no an international cutoffs for viruria and viremia, viral load of >104 copies/ml and >107 copies/ml have been strongly linked with nephropathy in renal transplant patients, respectively.,
In this study, we report a low specificity (67.5%). This finding disagrees with other reported studies, which reported higher specificity.,,, There are many factors that might contribute to the low specificity such as delayed delivery of urine samples, improper sample preparation and improper staining. In addition, high false positive cases may be due to the presence of nonspecific viral cytopathic changes, cellular degeneration and morphologic mimic of high grade urothelial carcinoma cells.
The negative predictive value (96.1%) of this study is higher than other studies,, and very close to the other study. However, the positive predictive value (35.1%) is less than other reported studies.,, In addition, this study shows an accuracy rate of 70.7%, which is in line with other similar studies.,, Other study which scored a high accuracy rate (97%), their comparison was between urine cytology and histopathological diagnosis of renal biopsy samples and not with RT-PCR as with others.
Several limitations of our study are worth noting. Firstly, this study is a retrospective study. Secondly, plasma samples for RT-PCR were processed abroad. Thirdly, urine RT-PCR was not measured as polyomaviruses remain positive in urine longer than in blood. Finally, the absence of histopathological diagnosis for renal biopsies.
In conclusion, the findings of this study show that the microscopic detection of decoy cells in urine samples is a sensitive screening method for polyomaviruses. The findings of this study are compatible with other similar studies.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Funahashi Y, Kato M, Fujita T, Takai S, Kimura Y, Gotoh M. Prevalence of polyomavirus positivity in urine after renal transplantation. Transplant Proc 2014;46:564-6.
Antonsson A, Pawlita M, Feltkamp MC, Bavinck J, Euvrard S, Harwood C, et al
. Longitudinal study of seroprevalence and serostability of the human polyomaviruses JCV and BKV in organ transplant recipients. J Med Virol 2013;85:327-35.
Demeter LM. JC, BK, and other polyomaviruses: Progressive multifocal leukoencephalopathy. In: Mandel GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. New York: Churchill Livingstone; 1995. p. 1400.
Rolla D, Giacomazzi CG, Gentile R, Ravetti JL, Cannella G, Varnier OE. Kidney graft loss associated with JC polyomavirus nephropathy. J Nephrol 2009;22:295-8.
Purighalla R, Shapiro R, McCauley J, Randhawa P. BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis 1995;26:671-3.
Qiao L, Qu Q, Jiang X. Clinical significance of quantitative and qualitative detection of BK and JC virus in blood and urine of renal transplantation recipients. Pak J Med Sci 2016;32:435-9.
Teutsch K, Schweitzer F, Knops E, Kaiser R, Pfister H, Di Cristanziano V, et al
. Early identification of renal transplant recipients with high risk of polyomavirus- associated nephropathy. Med Microbiol Immunol 2015;204:657-64.
Xing J, Procop GW, Reynolds JP, Chiesa-vottero A, Zhang Y. Diagnostic utility of urine cytology in early detection of polyomavirus in transplant patients. J Am Soc Cytopathol 2017;6:28-32.
Zalona A, Varella R, Takiya C, Goncalves R, Zalis M, Santoro-Lopes G. A qualitative seminested PCR assay as an alternative to urine cytology for BK polyomavirus screening after renal transplantation. Intervirology 2013;56:249-52.
Ranzi AD, Prolla JC, Keitel E, Brackmann R, Kist R, dos Santos GT, et al
. The role of urine cytology for 'decoy cells' as a screening tool in renal transplant recipients. Acta Cytologica 2012;56:543-7.
Randhawa P, Vats A, Shapiro R. Monitoring for polyomavirus BK and JC in urine: Comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 2005;79:984-6.
De Las Casas LE, Hoerl HD, Bardales RH, Pirsh JD, Sempf JM, Wetzel DJ, et al
. Utility of urinary cytology for diagnosing human polyoma virus infection in transplant recipients: A study of 37 cases with electron microscopic analysis. Diagn Cytopathol 2001;25:376-81.
Brennan DC, Agha I, Bohl DL, Schnitzler MA, Hardinger KL, Lockwood M, et al
. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005;5;582-94.
Hirsch HH, Brennan DC, Drachenberg CB, Ginevri F, Gordon J, Limaye AP, et al
. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005;79:1277-86.
Thamboo TP, Jeffery KJ, Friend PJ, Turner GD, Roberts IS. Urine cytology screening for polyomavirus infection following renal transplantation: The Oxford experience. J Clin Pathol 2007;60:927-30.
Kuypers DR, Vandooren AK, Lerut E, Evenepoel P, Claes K, Snoeck R, et al
. Adjuvant low-dosecidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005;5:1997-2004.
Hariharan S. BK virus nephritis after renal transplantation. Kidney Int 2006;69:655-62.
Drachenberg RC, Drachenberg CB, Papadimitriou JC, Ramos E, Fink JC, Wali R, et al
. Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology. Am J Transplant 2001;1:373-81.
Chakera A, Dyar OJ, Hughes E, Sophia B, David H, Ian R. Detection of polyomavirus BK reactivation after renal transplantation using an intensive decoy cell surveillance program is cost-effective. Transplantation 2011;92:1018-23.
Küpper T, Stoffels U, Pawlita M, Bürrig KF, Pfitzer P. Morphological changes in urothelial cells replicating human polyomavirus BK. Cytopathology 1993;4:361-8.
Itoh S, Irie K, Nakamura Y, Ohta Y, Haratake A, Morimatsu M. Cytologic and genetic study of polyomavirus-infected or polyomavirus-activated cells in human urine. Arch Pathol Lab Med 1998;122:333-7.
Kazory A, Ducloux D, Chalopin JM, Régis A, Bernard F, Hélène M. The first case of JC virus allograft nephropathy. Transplantation 2003;76:1653-5.
Wen MC, Wang CL, Wang M, Cheng C, Wu M, Chen C, et al
. Association of JC virus with tubule interstitial nephritis in a renal allograft recipient. J Med Virol 2004;72:675-8.
Koss LG, Sherman AB, Eppich E. Image analysis and DNA content of urothelial cells infected with human polyomavirus. Anal Quant Cytol 1984;6:89-94.
Hasegawa M, Ito T, Saigo K, Akutsu N, Maruyama M, Otsuki K, et al
. Association of DNA amplification with progress of BK polyomavirus infection and nephropathy in renal transplant recipients. Transpl Proc 2014;46:556-9.
Randhawa P, Ho A, Shapiro R, Vats A, Swalsky P, Finkelstein S, et al
. Correlates of quantitative measurement of BK polyomavirus (BKV) DNA with clinical course of BKV infection in renal transplant patients. J Clin Microbiol 2004;42:1176-80.
Rahamimov R, Lustig S, Tovar A, Yussim A, Bar-Nathan N, Shaharabani E, et al
. BK polyoma virus nephropathy in kidney transplant recipient: The role of new immunosuppressive agents. Transplant Proc 2003;35:604-5.
Chung BH, Hong YA, Kim HG, Sun IO, Choi SR, Park HS, et al
. Clinical usefulness of BK virus plasma quantitative PCR to prevent BK virus associated nephropathy. Transpl Int 2012;25:687-95.
Costa C, Bergallo M, Astegiano S, Terlizzi M, Sidoti F, Segoloni G, et al
. Monitoring of BK virus replication in the first year following renal transplantation. Nephrol Dial Transplant 2008;23:3333-6.
Viscount HB, Eid AJ, Espy MJ, Griffin MD, Thomsen KM, Harmsen WS, et al
. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 2007;84:340-45.
Sawinski D, Goral S. BK virus infection: An update on diagnosis and treatment. Nephrol Dial Transplant 2015;30:209-17.
Garces JC. BK virus-associated nephropathy in kidney transplant recipients. Ochsner J 2010;10:245-9.
Wiseman AC. Polyomavirus nephropathy: A current perspective and clinical considerations. Am J Kidney Dis 2009;54:131-42.
Drachenberg CB, Papadimitriou JC, Ramos E. Histologic versus molecular diagnosis of BK polyomavirus–associated nephropathy: A shifting paradigm? Clin J Am Soc Nephrol 2006;1:374-9.
Bechert CJ, Schnadig VJ, Payne DA, Dong J. Monitoring of BK viral load in renal allograft recipients by real time PCR assays. Am J Clin Pathol 2010;133;242-50.
Dr. Nasar Y Alwahaibi
Department of Allied Health Sciences, College of Medicine and Health Sciences, Sultan Qaboos University, P.O. Box 35 Postal Code 123, Muscat
Source of Support: None, Conflict of Interest: None
[Table 1], [Table 2]